Optimum Investment Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Optimum Investment Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$15K	–	958
2019 Q1	$15K	Hold	100	–	–	﹤0.01%	737
2018 Q4	$12K	Sell	100 -80	-44%	-$10.9K	﹤0.01%	724
2018 Q3	$29K	Buy	+180	New	+$27.2K	0.01%	657
2015 Q4	–	Sell	-3,300	Closed	-$334K	–	281
2015 Q3	$334K	Buy	+3,300	New	+$392K	0.13%	189
2015 Q1	$260K	Buy	+2,200	New	+$249K	0.08%	245

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Optimum Investment Advisors's FBT Position: Q2 2019 in Review

Optimum Investment Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 100 shares — an estimated $15K sold.

Optimum Investment Advisors first reported a position in FBT in Q1 2015 and held it in 5 quarters. The position peaked at $334K in Q3 2015. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

Optimum Investment Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
Optimum Investment Advisors sold 100 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $15K.
Optimum Investment Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 5 quarters.
Optimum Investment Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $334K in Q3 2015.
222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on Optimum Investment Advisors's 13F filing for Q2 2019, filed 29 Jul 2019.